Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Frontiers in Bioscience (Landmark Edition)|January 2, 2013
Biological significance and targeting of c-Met tyrosine kinase receptor in cancerLiliane Goetsch, Veronique Caussanel, Nathalie Corvaia
Nature Reviews. Immunology|April 24, 2010
Strategies and challenges for the next generation of therapeutic antibodiesAlain Beck, Thierry Wurch, Christian Bailly, et al.
Frontiers in Bioscience (Scholar Edition)|January 2, 2013
Insulin-like growth factor receptor type I as a target for cancer therapyNathalie Corvaia, Alain Beck, Véronique Caussanel, et al.
Medecine Sciences : M/S|December 29, 2009
[Protein scaffolds as alternatives to whole antibodies: from discovery research to clinical development]Thierry Wurch, Peter Lowe, Alain Beck, et al.
Biochemical Society Transactions|March 25, 2011
Tetraspanin CD151 as a target for antibody-based cancer immunotherapyJean-François Haeuw, Liliane Goetsch, Christian Bailly, et al.
Medecine Sciences : M/S|December 29, 2009
[Therapeutic antibodies and related products: choosing the right structure for success]Alain Beck, Elsa Wagner-Rousset, Thierry Wurch, et al.
Microorganisms|November 27, 2024
Narrative Review: Advancing Dysbiosis Treatment in Onco-Hematology with Microbiome-Based Therapeutic ApproachSalomé Biennier, Mathieu Fontaine, Aurore Duquenoy, et al.
European Journal of Cancer (Oxford, England : 1990)|April 25, 2007
Functional responses and in vivo anti-tumour activity of h7C10: a humanised monoclonal antibody with neutralising activity against the insulin-like growth factor-1 (IGF-1) receptor and insulin/IGF-1 hybrid receptorsGiuseppe Pandini, Thierry Wurch, Barbara Akla, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences|January 18, 2015
Characterization of antibody drug conjugate positional isomers at cysteine residues by peptide mapping LC-MS analysisMarie-Claire Janin-Bussat, Marina Dillenbourg, Nathalie Corvaia, et al.
Medecine Sciences : M/S|December 29, 2009
[The potential of monoclonal antibodies in cancer : established trastuzumab and cetuximab and promising targets IGF-1R and c-MET]Alexandre Bodmer, Liliane Goetsch, Laurence Favet, et al.
Pageof 3